ABSI - Absci Corp
IEX Last Trade
4.41
0.110 2.494%
Share volume: 673,601
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.30
0.11
2.56%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-09 | 2023-03-30 | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-03-21 | 2024-05-14 | |
| Assets | |||||||||
| Total Assets | 366.315 M | 339.387 M | 321.008 M | 295.808 M | 254.153 M | 236.344 M | 217.298 M | 274.898 M | |
| Current Assets | 227.888 M | 201.381 M | 186.863 M | 165.317 M | 148.037 M | 134.713 M | 120.578 M | 181.798 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 6.850 M | 5.049 M | 7.409 M | 6.032 M | 8.384 M | 5.199 M | 6.726 M | 3.905 M | |
| Short Term Investments | 6.850 M | 5.049 M | 7.409 M | 6.032 M | 8.384 M | 5.199 M | 6.726 M | 3.905 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 206.021 M | 181.312 M | 164.431 M | 144.258 M | 124.587 M | 113.479 M | 97.659 M | 161.543 M | |
| Total Non-current Assets | 138.427 M | 138.006 M | 134.145 M | 130.491 M | 106.116 M | 101.631 M | 96.720 M | 93.100 M | |
| Property Plant Equipment | 54.890 M | 55.466 M | 52.723 M | 50.166 M | 47.850 M | 45.213 M | 41.328 M | 38.755 M | |
| Other Assets | 7.049 M | 6.888 M | 6.601 M | 6.328 M | 6.426 M | 6.225 M | 6.027 M | 5.808 M | |
| Intangible Assets | 53.308 M | 52.465 M | 51.622 M | 50.780 M | 49.938 M | 49.095 M | 48.253 M | 47.411 M | |
| Goodwill | 21.335 M | 21.335 M | 21.335 M | 21.335 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 366.315 M | 339.387 M | 321.008 M | 295.808 M | 254.153 M | 236.344 M | 217.298 M | 274.898 M | |
| Total liabilities | 50.122 M | 46.445 M | 46.594 M | 41.843 M | 38.754 M | 39.928 M | 41.122 M | 34.791 M | |
| Total current liabilities | 31.692 M | 30.028 M | 30.270 M | 27.201 M | 25.484 M | 27.973 M | 29.558 M | 25.288 M | |
| Accounts Payable | 5.470 M | 1.858 M | 2.412 M | 1.933 M | 1.851 M | 1.909 M | 1.503 M | 1.653 M | |
| Other liabilities | 227.000 K | 33.000 K | 35.000 K | 0.000 | 0.000 | 0.000 | 999.000 K | 258.000 K | |
| Current long term debt | 6.370 M | 6.510 M | 6.932 M | 6.820 M | 6.420 M | 6.042 M | 5.578 M | 5.174 M | |
| Long term debt | 17.118 M | 15.628 M | 16.051 M | 14.418 M | 13.047 M | 11.706 M | 10.379 M | 9.070 M | |
| Other liabilities | 227.000 K | 33.000 K | 35.000 K | 0.000 | 0.000 | 0.000 | 999.000 K | 258.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 316.193 M | 292.942 M | 274.414 M | 253.965 M | 215.399 M | 196.416 M | 176.176 M | 240.107 M | |
| Common stock | 90.669 M | 91.105 M | 91.336 M | 91.479 M | 91.828 M | 92.217 M | 92.588 M | 99.393 M | |
| Retained earnings | -249.199 M | -276.458 M | -295.929 M | -319.284 M | -360.956 M | -382.950 M | -406.495 M | -428.470 M |